Hypoxia profoundly influences tumor biology by activating various cellular pathways. For instance, hypoxia-inducible factors (HIFs), particularly HIF-1α, become stabilized and active under low oxygen conditions, leading to the expression of genes that promote angiogenesis, metabolic adaptation, and survival. This adaptation allows cancer cells to thrive in hostile environments, contributing to tumor aggressiveness and resistance to therapy.
